Trip.com, IBD Stock Of The Day, Eyes Buy Point Amid 90% Rally For China Travel Leader

Trip.com, IBD Stock Of The Day, Eyes Buy Point Amid 90% Rally For China Travel Leader·Investor's Business Daily

Trip.com is heading toward a consolidation entry as the China travel player is building on its pandemic recovery.

Advertisement